Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom). (Q33383048)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom). |
scientific article |
Statements
1 reference
Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom). (English)
1 reference
Uwe Platzbecker
1 reference
Hermann Einsele
1 reference
Stefan Knop
1 reference
Christian Gerecke
1 reference
Peter Liebisch
1 reference
Max S Topp
1 reference
Orhan Sezer
1 reference
Christina Vollmuth
1 reference
Karina Falk
1 reference
Axel Glasmacher
1 reference
Uwe Maeder
1 reference
Ralf C Bargou
1 reference
30 January 2009
1 reference
Identifiers
1 reference